Management's discussion and analysis of results of operations and financial condition highlights the importance of mobilizing and deploying IT-based resources in combination with leveraging the value of other resources and capabilities. The firm’s IT capabilities represent the application of physical or intangible IT resources such as technology, knowledge, practices, relationships, management skills, and business process understanding to further organizational goals. The ability to provide data and information to users with appropriate levels of accuracy, timeliness, reliability, security, confidentiality, connectivity, and access is crucial for tailoring responses to changing business needs and directions. The firm’s long-term success depends on its ability to continually discover or acquire, develop, and commercialize innovative medicines, which is supported by strategic resource allocation and investment in technology resources. The management continuously evaluates liquidity and capital resources to ensure adequate financing for capital requirements, including potential business development activities, which encompass acquisitions, collaborations, investments, and licensing arrangements. The firm recognizes the significance of research and development spending across its portfolio of potential new medicines and indications, emphasizing the need for operational flexibility and efficient resource management. Challenges inherent in pharmaceutical research and development, including regulatory hurdles and market dynamics, necessitate a robust IT infrastructure to support decision-making processes and enhance operational efficiency. The firm’s investments in new facilities and manufacturing capacity aim to meet the significant demand for its products, indicating a strategic alignment of operational capabilities with market requirements. The management acknowledges the impact of external influences, such as regulatory changes and competitive actions, on its business strategies and operational performance. Furthermore, the firm’s approach to managing research and development resources reflects a commitment to optimizing process performance and enhancing organizational capabilities. The integration of digital technologies and innovation partnerships is essential for maintaining a competitive advantage and responding effectively to market restructuring and consumer demands. The firm’s ability to leverage big data and analytics is critical for improving performance metrics and achieving market-based performance outcomes. As part of its strategic management practices, the firm emphasizes the importance of information management and the deployment of IT systems to facilitate communication and coordination across internal processes and external relationships. The ongoing evaluation of investment choices and the management of operational risks are integral to the firm’s capability development and overall organizational effectiveness. The firm’s focus on digital transformation and the alignment of business strategies with technological advancements underscore its commitment to enhancing firm performance and creating business value in a rapidly evolving market environment.